Literature DB >> 20954645

Reduction of Nd:YAG capsulotomy rates after implantation of a single-piece acrylic hydrophilic intraocular lens with 360° squared optic edge: 24-month results.

Rashmi G Mathew1, Andrew G A Coombes.   

Abstract

BACKGROUND AND
OBJECTIVE: Posterior capsule opacification remains a significant problem following cataract surgery. The aim of the study was to evaluate the incidence of symptomatic posterior capsule opacification requiring Nd:YAG capsulotomy in patients who underwent cataract extraction and implantation of the Rayner C-flex 570C intraocular lens (IOL) (Rayner Intraocular Lens, Ltd., Sussex, UK). PATIENTS AND METHODS: A retrospective study of 3,461 eyes that underwent cataract extraction and insertion of the Rayner C-flex IOL from January 2004 to December 2005. The cases that received Nd: YAG capsulotomies were evaluated.
RESULTS: Over a 24-month period, 3,461 Rayner C-flex IOLs were implanted. Nd:YAG capsulotomy was performed in 58 of these cases. The rate of Nd:YAG capsulotomy was 0.6% at 12 months and 1.7% at 24 months. The mean time to Nd:YAG capsulotomy was 9.3 months (range: 1.3 to 22.7 months). The follow-up period was 5.3 to 29.0 months.
CONCLUSION: The incidence of symptomatic posterior capsule opacification with the Rayner C-flex IOL is low. Copyright 2010, SLACK Incorporated.

Entities:  

Mesh:

Year:  2010        PMID: 20954645     DOI: 10.3928/15428877-20100929-04

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  2 in total

1.  Intraocular lens-edge design and material factors contributing to posterior-capsulotomy rates: comparing Hoya FY60aD, PY60aD, and AcrySof SN60WF.

Authors:  Peter J Morgan-Warren; Jm Alaric Smith
Journal:  Clin Ophthalmol       Date:  2013-08-22

Review 2.  Factors Affecting Posterior Capsule Opacification in the Development of Intraocular Lens Materials.

Authors:  Grace Cooksley; Joseph Lacey; Marcus K Dymond; Susan Sandeman
Journal:  Pharmaceutics       Date:  2021-06-10       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.